News
EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
3 Best Tech Stocks for the Second Half of 2025
We're nearly halfway through 2025, and what a ride it's been for the stock market. As of this writing, the S&P 500, Nasdaq Composite, and Dow Jones Industrial Index are up 2%, up 1%, and down 1%,
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into
2 Stocks Down 34% and 40% to Buy Right Now
The first half of 2025 will draw to a close at the end of this month, and investors have been treated to some big twists and turns in the year so far. Despite some major sell-offs in the spring, the
Nvidia vs AMD: Who Will be the King of AI Chips?
Nvidia's (NASDAQ: NVDA) iron grip on AI chips faces a real challenger with Advanced Micro Devices' (NASDAQ: AMD). In this video, I compare the titans, break down the tech, and reveal who might rule
Here's How Many Shares of UnitedHealth Stock You Should Own to Get $1,000 in Yearly Dividends
If you're seeking dividend income, bravo -- because dividends are hard to beat. Healthy and growing dividend-paying stocks will keep sending you cash, no matter whether the economy is booming or
Humana Launches “Invite” Campaign to Inspire Active Aging Through Pickleball and Community Connection
Humana Inc. (NYSE: HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all
Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the
2 Top Stocks to Buy With Less Than $30
Though wealthy and successful investors garner much attention on Wall Street, equity markets are accessible to the average person. That's one of the great things about investing in stocks. Even with
Why AMD Stock Rallied On Monday, and Is This Just the Beginning?
In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and other artificial intelligence (AI) stocks. To learn more, check out the short video, consider
2 Dividend Stocks to Buy and Never Sell
There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in delivering strong market returns over long periods.
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
When it comes to healthcare stocks, many investors pay attention to the usual suspects: Eli Lilly, Novo Nordisk, CVS Health, or Johnson & Johnson. These companies have built up enormous brand equity
UnitedHealth Group Looks to Exit Latin America. Is This a Good Move for Investors, or a Sign of More Problems Ahead?
UnitedHealth Group (NYSE: UNH) is in the headlines again, this time, it's to announce that it is exiting Latin America. The announcement is just the latest in a series of news events in what has
After Plummeting 40%, Where Will UnitedHealth Group Stock Be in 1 Year? Here Is What History Suggests.
UnitedHealth Group (NYSE: UNH) has been one of the more interesting case studies in the stock market this year. Many stocks that have witnessed plummeting share prices can point to President Donald
EQS-Adhoc: Gerresheimer AG reacts to media reports
This Is Why AMD Stock Soared on Monday and Why It's Just the Start
In today's video, I will cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.
Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock
Pick a time frame -- year to date, last 12 months, last three years, last five years, or last 10 years. Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
You're unlikely to have a warm-and-fuzzy feeling after buying some stocks. Instead, some stocks can keep you awake at night because of their high volatility and risk. The good news, though, is that
These Were the 2 Worst-Performing Stocks in the S&P 500 in May 2025
The S&P 500 (SNPINDEX: ^GSPC) index, the most widely followed index in the stock market, briefly entered bear market territory in April but rebounded in May, much to investors' relief. Yet, although
Is Voyager Technologies Stock a Buy After Its Blockbuster IPO?
Most investors chasing the latest initial public offering (IPO) darling end up with a portfolio full of regrets. But occasionally, a company emerges with such compelling fundamentals and market
2 Top Stocks to Profit Off the AI and Cryptocurrency Booms
Artificial intelligence (AI) and cryptocurrency are two high-growth markets that offer promising return potential. Investing in the right stocks could pay off handsomely in the coming years. Here
AMD Just Changed the Game
In this video, I will cover the recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.
These Were the 2 Worst-Performing Stocks in the Nasdaq-100 in May 2025
The Nasdaq-100 market index holds a lot of volatile stocks. Some of its top performers seem overvalued today, while others seem to have room for further growth. The index as a whole rose 9.1% last
Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?
Several years ago I bought shares of 3M (NYSE: MMM) even though it was in the middle of a major class-action lawsuit. I believed the industrial giant would survive the legal issues, which it has




